首页> 外国专利> Lysimachia vulgaris var. davuricaLedebR.Kunth intracerebral hemorrhage intraventricular hemorrhage epidural hemorrhage subdural hemorrhage subarchnoid hemorrhage pharmaceutical

Lysimachia vulgaris var. davuricaLedebR.Kunth intracerebral hemorrhage intraventricular hemorrhage epidural hemorrhage subdural hemorrhage subarchnoid hemorrhage pharmaceutical

机译:Lysimachia Vulgaris var。 Davurica Leader.kunth脑内出血脑室出血硬膜外出血骨髓出血蛛网膜下腔出血药物

摘要

The present invention relates to a composition for preventing or treating cerebral hemorrhage-intracerebral hemorrhage, which contains tannins, saponins, and flavonoids as active ingredients from Milletae (Yellow Lotus) extract. More specifically, about two-thirds of the causes of cerebral hemorrhage-intracerebral hemorrhage occur between the ages of 45 and 75, and the most common cause is high blood pressure. In addition, amyloid angiopathy, aneurysm, arteriovenous malformation), moyamoya disease, hemophilia, leukemia, aplastic anemia, anticoagulant treatment, illegal drug misuse, brain tumor, heart disease, arteriosclerosis, diabetes, hyperlipidemia, tobacco, obesity, excessive drinking, oral contraceptives, viral infection, etc. It may cause bleeding. About two-thirds of patients with intraventricular hemorrhage fall into a coma within 12 hours and die of respiratory paralysis within 48 hours. The mortality rate is about 40-50%, and if the bleeding is more than 60cc, the mortality rate reaches 90%. In many cases, the after-effects are severe, so only about 20-30% of them recover to the extent that they can live independently. Tannins, saponins, flavonoids, or Albania tree (bark, leaf) extract Saponins, tannins, and vitamin c are derived from natural plants and are safe for consumers. or increase and have excellent efficacy in preventing or treating cerebral hemorrhage-intracerebral hemorrhage. The present invention has excellent efficacy in preventing or treating cerebral hemorrhage-intracerebral hemorrhage when tannin, saponin, flavonoid, or Albania (bark, leaf) extract saponin, tannin, and vitamin c are co-administered. Degree
机译:本发明涉及一种用于预防或治疗脑出血 - 脑内出血的组合物,其含有单宁,皂苷和黄酮类化合物,作为来自Milletae(黄色莲花)提取物的活性成分。更具体地,大约三分之二的脑出血 - 脑出血的原因发生在45%和75岁之间,最常见的原因是高血压。此外,淀粉样血管病变,动脉瘤,动脉畸形),莫达莎群病,血友病,白血病,血糖血症,抗凝治疗,非法药物滥用,脑肿瘤,心脏病,动脉硬化,糖尿病,高脂血症,烟草,肥胖,过度饮用,口服避孕药病毒感染等可能引起出血。大约三分之二的脑室出血患者在12小时内落入昏迷中,并在48小时内死于呼吸瘫痪。死亡率约为40-50%,如果出血超过60cc,死亡率率达到90%。在许多情况下,后续效果严重,所以只有约20-30%的人恢复到他们可以独立生活的程度。单宁,皂苷,黄酮类药物或阿尔巴尼亚树(树皮,叶)提取物皂苷,单宁和维生素C源自天然植物,对消费者安全。或增加并具有优异的治疗或治疗脑出血 - 脑内出血的疗效。本发明在单宁,皂苷,黄酮类药物或阿尔巴尼亚(树皮,叶)提取物皂苷,单宁和维生素C时,在预防或治疗脑出血 - 脑内出血具有优异的疗效。程度

著录项

  • 公开/公告号KR20210086915A

    专利类型

  • 公开/公告日2021-07-09

    原文格式PDF

  • 申请/专利权人 문상철;

    申请/专利号KR20190180207

  • 发明设计人 문상철;

    申请日2019-12-30

  • 分类号A61K36/185;A61K31/7052;A61K36/14;A61K36/48;A61P9/10;

  • 国家 KR

  • 入库时间 2022-08-24 20:06:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号